RXi Pharmaceuticals CEO Geert Cauwenbergh's 2018 pay jumps 44% to $610K
RXi Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: August 30, 2019
RXi Pharmaceuticals reported fiscal year 2018 executive compensation information on August 30, 2019.
In 2018, two executives at RXi Pharmaceuticals received on average a compensation package of $518K, a 68% increase compared to previous year.
Average pay of disclosed executives at RXi Pharmaceuticals
Geert Cauwenbergh, Chief Executive Officer, received $610K in total, which increased by 44% compared to 2017. 69% of Cauwenbergh's compensation, or $420K, was in salary. Cauwenbergh also received $116K in non-equity incentive plan, $36K in option awards, $38K in stock awards, as well as $606 in other compensation.
Gerrit Dispersyn, Chief Executive Officer, received a compensation package of $425K, which increased by 84% compared to previous year. 74% of the compensation package, or $316K, was in salary.
Related executives
You may also like
Source: SEC filing on August 30, 2019.